心力衰竭患者的症状感知干预措施的有效性:系统性审查和元分析
Xiangyu Wang1,2, Guangju Wang1,2, Yichen Liu1,2
1Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.
Frontiers in cardiovascular medicine
|March 12, 2026
概括
症状感知干预改善了心力衰竭患者的自我护理和生活质量,但并没有减少住院治疗或死亡率. 这些发现为改进未来的干预策略提供了洞察力.
科学领域:
- 心脏病学 心脏病学
- 健康心理学 心理健康心理学
- 基于证据的医学基于证据的医学.
背景情况:
- 症状感知干预措施有望改善心力衰竭 (HF) 患者的生活质量.
- 缺乏关于这些干预措施对HF临床结果的有效性的定量数据.
- 这一元分析系统地评估了症状感知干预措施对HF患者结果的影响.
研究的目的:
- 确定症状感知干预措施对HF患者症状感知的影响 (主要结果).
- 评估对二次结果的影响,包括自我护理,HF知识,自我护理有效性,生活质量,再住院,急诊室访问和死亡率.
- 提供现有研究对高频的症状感知干预措施的定量综合.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和CINAHL的系统文献搜索,截至2025年3月31日.
- 包括随机对照试验 (RCT),评估HF患者的症状感知干预措施.
- 使用STATA 17.0进行元分析,并使用ROB2.0评估偏差风险.
主要成果:
- 八个RCT包括1030名患者被纳入了分析.
- 干预措施没有显著减少再住院,急诊室访问或死亡率.
- 在症状感知 (SMD: 0.579),自我护理 (SMD: 0.697),HF知识 (SMD: 1.481),自我护理有效性 (MD: 7.875) 和生活质量 (MD: -8.240) 中观察到显著改善.
结论:
- 症状感知干预措施有效地提高了HF患者的症状感知,自我护理,知识,疗效和生活质量.
- 目前,这些干预措施没有显著影响到减少再住院,急诊室访问或死亡率.
- 这些发现支持优化症状感知干预策略,用于未来的研究和心力衰竭管理中的临床应用.
相关概念视频
Heart Failure VII: Nursing Interventions
629
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
629
Heart Failure VI: Adjunct Therapies
496
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
496
Heart Failure V: Medical Management
455
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
455
Cardiomyopathy VI: Nursing Management
433
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
433
Heart Failure III: Clinical Manifestations
761
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
761
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
